Last reviewed · How we verify
Proflavine, high resolution imaging — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Proflavine, high resolution imaging (Proflavine, high resolution imaging) — Anandasabapathy, Sharmila, M.D..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Proflavine, high resolution imaging TARGET | Proflavine, high resolution imaging | Anandasabapathy, Sharmila, M.D. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Proflavine, high resolution imaging CI watch — RSS
- Proflavine, high resolution imaging CI watch — Atom
- Proflavine, high resolution imaging CI watch — JSON
- Proflavine, high resolution imaging alone — RSS
Cite this brief
Drug Landscape (2026). Proflavine, high resolution imaging — Competitive Intelligence Brief. https://druglandscape.com/ci/proflavine-high-resolution-imaging. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing